Medical Devices APAC

APAC Smart Inhalers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Smart Inhalers Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $52.6 Mn Placeholder estimate
Estimate 2025 $63.8 Mn 22.2% of the global market
Projected 2034 $365.5 Mn 472.8% Adds $301.7 Mn over 9 forecast years
CAGR 2025–2034 21.4% Faster than 95% of 173 Medical Devices markets here
Key players 5
  • APAC is 22.16% of the global market.
  • Among regions, the largest is North America at $137.1 Mn.
  • Fastest growing: APAC (this report) at 21.4% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$301.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smart Inhalers Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $52.6 Mn — —
2025 (base) $63.8 Mn +$11.2 Mn —
2026 (forecast) $77.5 Mn +$13.7 Mn +21.4%
2027 (forecast) $94.1 Mn +$16.6 Mn +47.4%
2028 (forecast) $114.2 Mn +$20.1 Mn +78.9%
2029 (forecast) $138.6 Mn +$24.4 Mn +117.2%
2030 (forecast) $168.3 Mn +$29.7 Mn +163.7%
2031 (forecast) $204.3 Mn +$36.0 Mn +220.1%
2032 (forecast) $248.0 Mn +$43.7 Mn +288.6%
2033 (forecast) $301.1 Mn +$53.1 Mn +371.8%
2034 (forecast) $365.5 Mn +$64.4 Mn +472.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $288.0 Mn
  2. North America $137.1 Mn
  3. US $128.3 Mn
  4. APAC (this report) $63.8 Mn
  5. Europe $60.6 Mn
  6. China $27.2 Mn
  7. Canada $20.8 Mn
  8. Japan $16.7 Mn
  9. Middle East $13.3 Mn
  10. Latin America $12.4 Mn
  11. Germany $10.9 Mn
  12. France $8.3 Mn
  13. UK $8.0 Mn
  14. Italy $7.2 Mn
  15. Brazil $7.3 Mn
  16. Ecuador $6.3 Mn
  17. India $5.9 Mn
  18. Spain $4.9 Mn
  19. Africa $5.0 Mn
  20. Mexico $4.2 Mn
  21. Saudi Arabia $4.3 Mn
  22. Australia $3.2 Mn
  23. Russia $2.6 Mn
  24. New Zealand $2.5 Mn
  25. South Africa $1.9 Mn
  26. UAE $1.3 Mn
  27. Egypt $0.9 Mn
  28. Philippines $0.6 Mn
  29. Hong Kong $0.4 Mn
  30. Malaysia $0.4 Mn
  31. Kenya $0.3 Mn
  32. Singapore $0.3 Mn
  33. Thailand $0.3 Mn

Report snapshot

APAC Smart Inhalers Market Analysis at a glance
Market size, 2025$63.8 Mn placeholder estimate
Forecast, 2034$365.5 Mn placeholder estimate
Growth (CAGR), 2025–203421.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersPropeller Health, Adherium, Teva Pharmaceutical, AstraZeneca, Cohero Health (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Smart Inhalers Market Analysis Executive Summary

Smart inhalers record when and how a patient uses an inhaler and send reminders, helping control asthma and COPD.

Key segments of the smart Inhalers market include product (Inhaler Add-On Sensors and Integrated Smart Inhalers) and indication (Asthma and COPD).

Bar chart: Asia Pacific Smart Inhalers market size, 2024–2034, placeholder estimates. $52.6 Mn in 2024, $63.8 Mn in 2025 and $365.5 Mn in 2034, 21.4% CAGR.
Asia Pacific Smart Inhalers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Smart Inhalers Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the smart Inhalers market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the smart Inhalers market.

Competitive Landscape for Smart Inhalers Market in APAC

The smart Inhalers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smart Inhalers Market in APAC

Smart Inhalers in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9] and Thai FDA (Thailand)⁠[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[11], basic medical insurance (China)⁠[12], the Hospital Authority (Hong Kong)⁠[13], Ayushman Bharat PM-JAY (India)⁠[14], public health insurance (Japan)⁠[15], subsidised public care (Malaysia)⁠[16], Pharmac (New Zealand)⁠[17], PhilHealth (Philippines)⁠[18], MediShield Life (Singapore)⁠[19] and the Universal Coverage Scheme (Thailand)⁠[20].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[12] National Healthcare Security Administration. Checked 14 Nov 2026.

[13] Hospital Authority. Checked 14 Nov 2026.

[14] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[15] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[16] Ministry of Health Malaysia. Checked 14 Nov 2026.

[17] Pharmac. Checked 14 Nov 2026.

[18] PhilHealth. Checked 14 Nov 2026.

[19] CPF Board, MediShield Life. Checked 14 Nov 2026.

[20] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how smart Inhalers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smart Inhalers right now, from free public sources.

Latest research 47 papers since 2021 (worldwide)

  1. Effectiveness of digital health interventions for asthma management: an umbrella review protocol. JBI evidence synthesis, 2026
  2. Parent perspectives on the potential use of smart inhalers for asthma management in children: a qualitative interview study. The Journal of asthma : official journal of the Association for the Care of Asthma, 2026
  3. Smart Inhaler Parameters for Identifying Clinical Worsening in COPD, Leading Up to an Exacerbation: A Pilot Study. COPD, 2026
  4. Artificial Intelligence-Based Optimization of Pulmonary Drug Delivery Performance in Smart Inhaler Drug-Device Combination Systems. Pharmaceutics, 2026
  5. [Current issues and digital technologies in pulmonary rehabilitation]. Orvosi hetilap, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smart Inhalers in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smart Inhalers market in Asia Pacific?
Placeholder estimate: about $63.8 Mn in 2025, rising to about $365.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smart Inhalers market in Asia Pacific growing?
Placeholder estimate: about 21.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smart Inhalers market report cover?
The report splits the market by product (Inhaler Add-On Sensors, Integrated Smart Inhalers), indication (Asthma, COPD) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Smart Inhalers market?
Key players include Propeller Health, Adherium, Teva Pharmaceutical, AstraZeneca and Cohero Health.
What is driving the Smart Inhalers market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.
How much research is published on Smart Inhalers?
PubMed lists 47 papers on Smart Inhalers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Smart Inhalers in APAC? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Airway Management Devices: Critical Tools in EmergenciesKeeping the airway open is the first step in saving a life. More than half of deaths in low- and… Anaesthesia and Respiratory Devices: Lessons After COVIDMore than 5 billion people lack access to safe, affordable medical oxygen. COVID-19 exposed gaps in… Snoring and Sleep Apnoea Devices: Sleeping BetterAn estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Back to Catalogue
Keep exploring

Related Medical Devices reports in APAC

See all
Same topic, other categories

Related on respiratory and remote monitoring and wearables

See the topic